Published in Virology on October 25, 2002
The molecular population genetics of HIV-1 group O. Genetics (2004) 4.53
Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J Virol (2004) 1.61
Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat Struct Mol Biol (2009) 1.53
Lack of adaptation to human tetherin in HIV-1 group O and P. Retrovirology (2011) 1.14
Non-M variants of human immunodeficiency virus type 1. Clin Microbiol Rev (2013) 1.05
Divergent evolution in reverse transcriptase (RT) of HIV-1 group O and M lineages: impact on structure, fitness, and sensitivity to nonnucleoside RT inhibitors. J Virol (2010) 1.01
Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays. J Clin Microbiol (2006) 1.00
Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol (2009) 0.97
Baseline genotypic and phenotypic susceptibilities of HIV-1 group O to enfuvirtide. Antimicrob Agents Chemother (2010) 0.86
Clinical evaluation of BioPlex 2200 HIV Ag-Ab, an automated screening method providing discrete detection of HIV-1 p24 antigen, HIV-1 antibody, and HIV-2 antibody. J Clin Microbiol (2013) 0.83
A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J Clin Microbiol (2011) 0.81
HIV-1 group O infection in Cameroon from 2006 to 2013: Prevalence, genetic diversity, evolution and public health challenges. Infect Genet Evol (2015) 0.80
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon. PLoS Pathog (2015) 0.78
Overview of HIV molecular epidemiology among people who inject drugs in Europe and Asia. Infect Genet Evol (2016) 0.75
Human Immunodeficiency Virus (HIV). Transfus Med Hemother (2016) 0.75
V1/V2 Neutralizing Epitope is Conserved in Divergent Non-M Groups of HIV-1. J Acquir Immune Defic Syndr (2016) 0.75
Characterization of HIV type 1 envelope sequence among viral isolates circulating in the northern region of Colombia, South America. AIDS Res Hum Retroviruses (2012) 0.75
Performance of the Liaison XL Murex HIV Ab/Ag test on clinical samples representing current epidemic HIV variants. J Clin Microbiol (2014) 0.75
Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon. Retrovirology (2017) 0.75
Novel Time-Resolved Fluorescence Europium Nanoparticle Immunoassay for Detection of Human Immunodeficiency Virus-1 Group O Viruses Using Microplate and Microchip Platforms. AIDS Res Hum Retroviruses (2016) 0.75
Origin of HIV-1 in the chimpanzee Pan troglodytes troglodytes. Nature (1999) 10.97
Isolation of a new human retrovirus from West African patients with AIDS. Science (1986) 7.97
Antiretroviral drug resistance testing in adult HIV-1 infection: recommendations of an International AIDS Society-USA Panel. JAMA (2000) 7.81
HIV-1 nomenclature proposal. Science (2000) 6.61
Recombination in HIV-1. Nature (1995) 5.72
Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A (1991) 5.07
Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med (1998) 4.92
Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med (1999) 4.79
Antiretroviral drug resistance testing in adults with HIV infection: implications for clinical management. International AIDS Society--USA Panel. JAMA (1998) 4.42
Macrophage activation switching: an asset for the resolution of inflammation. Clin Exp Immunol (2005) 3.84
The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol (1996) 3.82
Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology. J Virol (1994) 3.70
Transmission of the BSE agent to mice in the absence of detectable abnormal prion protein. Science (1997) 3.68
A comprehensive panel of near-full-length clones and reference sequences for non-subtype B isolates of human immunodeficiency virus type 1. J Virol (1998) 3.65
Multiple evolutionary origins of prochlorophytes within the cyanobacterial radiation. Nature (1992) 3.54
Behavioural disorders, Parkinson's disease and subthalamic stimulation. J Neurol Neurosurg Psychiatry (2002) 3.41
Inactivation of lymphadenopathy-associated virus by heat, gamma rays, and ultraviolet light. Lancet (1985) 3.27
Mosaic genome structure of simian immunodeficiency virus from west African green monkeys. EMBO J (1994) 3.19
Neurosurgery at an earlier stage of Parkinson disease: a randomized, controlled trial. Neurology (2006) 2.90
Prediction of malignant middle cerebral artery infarction by diffusion-weighted imaging. Stroke (2000) 2.59
European guidelines on the clinical management of HIV-1 tropism testing. Lancet Infect Dis (2011) 2.47
False-negative diffusion-weighted MR findings in acute ischemic stroke. AJNR Am J Neuroradiol (2000) 2.42
BSE transmission to macaques. Nature (1996) 2.32
Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg (2000) 2.25
HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet (1994) 2.25
Nucleotide sequence and analysis of the lethal factor gene (lef) from Bacillus anthracis. Gene (1989) 2.24
Near full-length clones and reference sequences for subtype C isolates of HIV type 1 from three different continents. AIDS Res Hum Retroviruses (2001) 2.23
Human immunodeficiency virus. Phylogeny and the origin of HIV-1. Nature (2001) 2.20
env sequences of simian immunodeficiency viruses from chimpanzees in Cameroon are strongly related to those of human immunodeficiency virus group N from the same geographic area. J Virol (2000) 2.17
The 37-kDa/67-kDa laminin receptor acts as the cell-surface receptor for the cellular prion protein. EMBO J (2001) 2.16
Identification of interaction domains of the prion protein with its 37-kDa/67-kDa laminin receptor. EMBO J (2001) 2.10
Changes in human immunodeficiency virus type 1 populations after treatment interruption in patients failing antiretroviral therapy. J Virol (2001) 2.08
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up. J Neurol Neurosurg Psychiatry (2005) 2.08
Genetic diversity and HIV detection by polymerase chain reaction. Lancet (1995) 2.03
Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet (2004) 2.02
Preferential host switching by primate lentiviruses can account for phylogenetic similarity with the primate phylogeny. Syst Biol (2002) 2.00
Variability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in France. J Virol (1995) 1.99
Simian immunodeficiency viruses from central and western Africa: evidence for a new species-specific lentivirus in tantalus monkeys. J Virol (1993) 1.98
Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization. AIDS Res Hum Retroviruses (1994) 1.97
Wild Mandrillus sphinx are carriers of two types of lentivirus. J Virol (2001) 1.96
Prevalence of antibodies to lymphadenopathy-associated retrovirus in African patients with AIDS. Science (1984) 1.95
Diffusion-weighted MRI in acute stroke within the first 6 hours: 1.5 or 3.0 Tesla? Neurology (2010) 1.94
Characterization of the RNA dependent DNA polymerase of a new human T-lymphotropic retrovirus (lymphadenopathy associated virus). Biochem Biophys Res Commun (1984) 1.94
Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group. JAMA (1996) 1.94
A serological survey of Ebola virus infection in central African nonhuman primates. J Infect Dis (2004) 1.86
Autism, language delay and mental retardation in a patient with 7q11 duplication. J Med Genet (2007) 1.86
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet (2008) 1.83
Origins and evolution of AIDS viruses. Biol Bull (1999) 1.77
Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res Hum Retroviruses (2001) 1.77
Structural brain changes in tinnitus. Cereb Cortex (2005) 1.71
Are the brains of monozygotic twins similar? A three-dimensional MR study. AJNR Am J Neuroradiol (1998) 1.71
Antimoniotungstate (HPA 23) treatment of three patients with AIDS and one with prodrome. Lancet (1985) 1.70
Pallidal stimulation for Parkinson's disease. Two targets? Neurology (1997) 1.69
Cross-species transmission and recombination of 'AIDS' viruses. Philos Trans R Soc Lond B Biol Sci (1995) 1.68
MR determination of hippocampal volume: comparison of three methods. AJNR Am J Neuroradiol (1996) 1.66
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants. J Virol (1998) 1.65
Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses. J Virol (1997) 1.64
Destructive arthropathy in chondrocalcinosis articularis. Arthritis Rheum (1976) 1.63
Evolution and probable transmission of intersubtype recombinant human immunodeficiency virus type 1 in a Zambian couple. J Virol (1997) 1.62
Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet (1994) 1.61
Tourette's syndrome and deep brain stimulation. J Neurol Neurosurg Psychiatry (2005) 1.60
Population pharmacokinetics of tenofovir in HIV-1-infected pregnant women and their neonates (ANRS 12109). Clin Pharmacol Ther (2008) 1.56
Failure of long-term pallidal stimulation corrected by subthalamic stimulation in PD. Neurology (2000) 1.55
Detection of diverse variants of human immunodeficiency virus-1 groups M, N, and O and simian immunodeficiency viruses from chimpanzees by using generic pol and env primer pairs. J Infect Dis (2000) 1.52
Structural analysis of the intracellular RNAs of murine mammary tumor virus. J Virol (1979) 1.52
Molecular cloning and expression in Escherichia coli of the lethal factor gene of Bacillus anthracis. Gene (1986) 1.51
Developmental abnormalities of the medial temporal lobe in patients with temporal lobe epilepsy. AJNR Am J Neuroradiol (1995) 1.49
K-complex-induced seizures in autosomal dominant nocturnal frontal lobe epilepsy. Clin Neurophysiol (2008) 1.47
HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro. J Antimicrob Chemother (2008) 1.47
Reliability of the ECASS radiological classification of postthrombolysis brain haemorrhage: a comparison of CT and three MRI sequences. Cerebrovasc Dis (2010) 1.46
Adaptation of the bovine spongiform encephalopathy agent to primates and comparison with Creutzfeldt-- Jakob disease: implications for human health. Proc Natl Acad Sci U S A (2001) 1.46
NMR evidence for gapped spin excitations in metallic carbon nanotubes. Phys Rev Lett (2005) 1.44
Sporadic CJD clinically mimicking variant CJD with bilateral increased signal in the pulvinar. Neurology (2002) 1.43
Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS (1996) 1.42
Early viral replication in the brain of SIV-infected rhesus monkeys. Am J Pathol (1991) 1.42
Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods (1998) 1.41
HIV-1 group O infection in Cameroon, 1986 to 1998. Emerg Infect Dis (2001) 1.41
A highly defective HIV-1 strain isolated from a healthy Gabonese individual presenting an atypical western blot. AIDS (1989) 1.40
Variability of human immunodeficiency virus type 2 (hiv-2) infecting patients living in france. Virology (2001) 1.40
HIV-1 subtypes and plasma RNA quantification. AIDS (1999) 1.40